Endoscopic mucosal resection is a method utilized for the treatment and staging of superficial neoplasms of the GI area. This method was first formulated in Japan for the cure of early gastric cancer plus has afterward increased in usage all around the world for several indications, with sessile colonic neoplasms and dysplastic Barrett mucosa. The efficacy of EMR remains in its aptitude to offer exact histologic staging of apparent GI neoplasms as well as offering a simply invasive technique for elimination of apparent malignancies. Endoscopic mucosal resection is applicable in indications such as colon cancer, duodenal cancer, stomach cancer and esophageal cancer.
The worldwide market will be accounting for a valuation of more than US$ 2,500 Million through the end of the predicted year 2025, up from a market valuation of around US$ 1,400 Million during the year 2017. The revenue growth of the worldwide market is also projected to increase at a healthy 7.3% CAGR for the predicted duration of 2017-2025. The expansion is the outcome of new technological progressions and the manufacturers are gearing up to make full utilization of it through the introduction of fresh products in the market.
Global Endoscopic Mucosal Resection Market Projected to Exhibit a strong CAGR of 7.3% Through 2025
Key Market Players
The major companies operating in the worldwide market for endoscopic mucosal resection include
2018 Â© Research Solution Insights. All Rights Reserved.